These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 25405368)
1. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer. Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368 [TBL] [Abstract][Full Text] [Related]
2. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma. Fukumoto I; Koshizuka K; Hanazawa T; Kikkawa N; Matsushita R; Kurozumi A; Kato M; Okato A; Okamoto Y; Seki N Int J Oncol; 2016 Sep; 49(3):1119-29. PubMed ID: 27573718 [TBL] [Abstract][Full Text] [Related]
3. Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma. Ishihara T; Seki N; Inoguchi S; Yoshino H; Tatarano S; Yamada Y; Itesako T; Goto Y; Nishikawa R; Nakagawa M; Enokida H J Urol; 2014 Dec; 192(6):1822-30. PubMed ID: 25014580 [TBL] [Abstract][Full Text] [Related]
4. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster. Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312 [TBL] [Abstract][Full Text] [Related]
5. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related. Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757 [TBL] [Abstract][Full Text] [Related]
6. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma. Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691 [TBL] [Abstract][Full Text] [Related]
7. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer. Goto Y; Kojima S; Nishikawa R; Enokida H; Chiyomaru T; Kinoshita T; Nakagawa M; Naya Y; Ichikawa T; Seki N Oncotarget; 2014 Sep; 5(17):7748-59. PubMed ID: 25115396 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of MicroRNA-27b Inhibits Proliferation, Migration, and Invasion via Suppression of MET Expression. Zhou H; Liu Y; Xiao L; Hu Z; Xia K Oncol Res; 2017 Jan; 25(1):147-154. PubMed ID: 28081743 [TBL] [Abstract][Full Text] [Related]
9. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells. Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597 [TBL] [Abstract][Full Text] [Related]
10. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness. Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587 [TBL] [Abstract][Full Text] [Related]
11. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. Yamasaki T; Yoshino H; Enokida H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Fuse M; Seki N; Nakagawa M Int J Oncol; 2012 Jun; 40(6):1821-30. PubMed ID: 22378464 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. Majid S; Dar AA; Saini S; Deng G; Chang I; Greene K; Tanaka Y; Dahiya R; Yamamura S PLoS One; 2013; 8(7):e67686. PubMed ID: 23844063 [TBL] [Abstract][Full Text] [Related]
13. Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma. Mataki H; Seki N; Chiyomaru T; Enokida H; Goto Y; Kumamoto T; Machida K; Mizuno K; Nakagawa M; Inoue H Int J Oncol; 2015 Mar; 46(3):1039-50. PubMed ID: 25522678 [TBL] [Abstract][Full Text] [Related]
14. miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study. Hannafon BN; Cai A; Calloway CL; Xu YF; Zhang R; Fung KM; Ding WQ BMC Cancer; 2019 Jun; 19(1):642. PubMed ID: 31253120 [TBL] [Abstract][Full Text] [Related]
15. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer. Yonemori M; Seki N; Yoshino H; Matsushita R; Miyamoto K; Nakagawa M; Enokida H Cancer Sci; 2016 Sep; 107(9):1233-42. PubMed ID: 27355528 [TBL] [Abstract][Full Text] [Related]
16. The MicroRNA-23b/27b/24 Cluster Facilitates Colon Cancer Cell Migration by Targeting FOXP2. Nishida K; Kuwano Y; Rokutan K Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936744 [TBL] [Abstract][Full Text] [Related]
17. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539 [TBL] [Abstract][Full Text] [Related]
18. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer. Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890 [TBL] [Abstract][Full Text] [Related]
19. Novel role of the clustered miR-23b-3p and miR-27b-3p in enhanced expression of fibrosis-associated genes by targeting TGFBR3 in atrial fibroblasts. Yang Z; Xiao Z; Guo H; Fang X; Liang J; Zhu J; Yang J; Li H; Pan R; Yuan S; Dong W; Zheng XL; Wu S; Shan Z J Cell Mol Med; 2019 May; 23(5):3246-3256. PubMed ID: 30729664 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]